Loading...
SOPHiA GENETICS S.A.
SOPH•NASDAQ
Healthcare
Medical - Healthcare Information Services
$3.60
$-0.01(-0.28%)
SOPHiA GENETICS S.A. (SOPH) Financial Performance & Income Statement Overview
Review SOPHiA GENETICS S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.49%
↑ 4.49%
Operating Income Growth
11.04%
↑ 11.04%
Net Income Growth
20.88%
↑ 20.88%
Operating Cash Flow Growth
11.84%
↑ 11.84%
Operating Margin
-95.14%
↓ 95.14%
Gross Margin
68.09%
↑ 68.09%
Net Profit Margin
-98.51%
↓ 98.51%
ROE
-63.47%
↓ 63.47%
ROIC
-54.26%
↓ 54.26%
SOPHiA GENETICS S.A. (SOPH) Income Statement & Financial Overview
Review SOPHiA GENETICS S.A.'s (SOPH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $17.73M | $15.85M | $15.81M | $15.78M |
| Cost of Revenue | $5.63M | $5.20M | $5.03M | $5.37M |
| Gross Profit | $12.10M | $10.65M | $10.78M | $10.40M |
| Gross Profit Ratio | $0.68 | $0.67 | $0.68 | $0.66 |
| R&D Expenses | $9.14M | $7.87M | $7.96M | $9.39M |
| SG&A Expenses | $20.52M | $18.19M | $17.84M | $19.78M |
| Operating Expenses | $29.55M | $26.02M | $25.80M | $29.17M |
| Total Costs & Expenses | $35.18M | $31.22M | $30.83M | $34.54M |
| Interest Income | $1.89M | $267000.00 | $450000.00 | $758000.00 |
| Interest Expense | $1.91M | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.29M | $2.21M | $2.04M | $2.06M |
| EBITDA | -$12.23M | -$13.15M | -$12.99M | -$17.42M |
| EBITDA Ratio | -$0.69 | -$0.83 | -$0.82 | -$1.10 |
| Operating Income | -$17.44M | -$15.41M | -$15.02M | -$18.76M |
| Operating Income Ratio | -$0.98 | -$0.97 | -$0.95 | -$1.19 |
| Other Income/Expenses (Net) | $2.90M | -$2.90M | -$27000.00 | $5.37M |
| Income Before Tax | -$14.54M | -$18.31M | -$15.03M | -$13.39M |
| Income Before Tax Ratio | -$0.82 | -$1.15 | -$0.95 | -$0.85 |
| Income Tax Expense | $616000.00 | $130000.00 | $161000.00 | $316000.00 |
| Net Income | -$15.16M | -$18.44M | -$15.19M | -$13.70M |
| Net Income Ratio | -$0.85 | -$1.16 | -$0.96 | -$0.87 |
| EPS | -$0.23 | -$0.28 | -$0.23 | -$0.21 |
| Diluted EPS | -$0.23 | -$0.28 | -$0.23 | -$0.21 |
| Weighted Avg Shares Outstanding | $66.67M | $66.38M | $65.92M | $65.31M |
| Weighted Avg Shares Outstanding (Diluted) | $66.67M | $66.38M | $65.92M | $65.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan